Table 3 Characteristic distribution comparison among different COPD GOLD stage groups
Characteristic | COPD GOLD stage | P value | |||
|---|---|---|---|---|---|
1 (N = 13) | 2 (N = 60) | 3 (N = 66) | 4 (N = 16) | ||
Sex | 0.032 | ||||
Male | 10 (7.41%) | 50 (37.04%) | 60 (44.44%) | 15 (11.11%) | |
Female | 3 (15%) | 11 (55%) | 5 (25%) | 1 (5%) | |
Age | 0.001 | ||||
< 60 | 2 (15.38%) | 10 (76.92%) | 1 (7.69%) | 0 (0%) | |
60–69 | 4 (7.84%) | 24 (47.06%) | 18 (35.29%) | 5 (9.80%) | |
70–79 | 5 (8.62%) | 21 (36.21%) | 28 (48.28%) | 4 (6.90%) | |
≥ 80 | 2 (6.06%) | 6 (18.18%) | 18 (54.55%) | 7 (21.21%) | |
Height | 0.101 | ||||
< 155 | 2 (16.67%) | 7 (58.33%) | 3 (25%) | 0 (0%) | |
155–164 | 4 (6.67%) | 21 (35%) | 27 (45%) | 8 (13.33%) | |
165–174 | 7 (9.46%) | 30 (40.54%) | 30 (40.54%) | 7 (9.46%) | |
≥ 175 | 0 (0%) | 3 (33.33%) | 5 (55.56%) | 1 (11.11%) | |
Weight | 0.035 | ||||
< 50 | 0 (0%) | 5 (26.32%) | 13 (68.42%) | 1 (5.26%) | |
50–59 | 1 (3.13%) | 11 (34.38%) | 19 (59.38%) | 1 (3.13%) | |
60–69 | 3 (4.84%) | 28 (45.16%) | 20 (32.26%) | 11 (17.74%) | |
≥ 70 | 9 (21.43%) | 17 (40.48%) | 13 (30.95%) | 3 (7.14%) | |
BMI | 0.038 | ||||
< 18.5 | 0 (0%) | 6 (30%) | 13 (65%) | 1 (5%) | |
18.5–24.5 | 3 (4%) | 28 (37.33%) | 35 (46.67%) | 9 (12%) | |
24.5–30 | 9 (17.31%) | 23 (44.23%) | 14 (26.92%) | 6 (11.54%) | |
> 30 | 1 (12.50%) | 4 (50%) | 3 (37.50%) | 0 (0%) | |
NEU% | < 0.001 | ||||
< 70 | 9 (15.25%) | 30 (50.85%) | 19 (32.20%) | 1 (1.69%) | |
70–80 | 3 (6.98%) | 18 (41.86%) | 17 (39.53%) | 5 (11.63%) | |
> 80 | 1 (1.89%) | 13 (24.53%) | 29 (54.72%) | 10 (18.87%) | |